{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:16:20Z","timestamp":1790630180969,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Foundation \u2013 Flanders","award":["G0C8517N"],"award-info":[{"award-number":["G0C8517N"]}]},{"name":"Research Foundation - Flanders","award":["G0C8517N"],"award-info":[{"award-number":["G0C8517N"]}]},{"name":"VIB Grand Challenges Program"},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10875-020-00883-7","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T19:03:41Z","timestamp":1601751821000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-5933","authenticated-orcid":false,"given":"Quentin","family":"Neven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelyse","family":"Bruwier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"de Ville de Goyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Moens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Brichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,4]]},"reference":[{"key":"883_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","volume":"98","author":"J Wang","year":"1999","unstructured":"Wang J, Zheng L, Lobito A, Ka-Ming Chan F, Dale J, Snelleret M, et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98:47\u201358.","journal-title":"Cell"},{"key":"883_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","volume":"131","author":"A Magerus-Chatinet","year":"2013","unstructured":"Magerus-Chatinet A, Stolzenberg M-C, Lanzarotti N, Neven B, Daussy C, Picard C, et al. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation. J Allergy Clin Immunol. 2013;131:486\u201390.","journal-title":"J Allergy Clin Immunol"},{"issue":"18","key":"883_CR3","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798\u2013807.","journal-title":"Blood"},{"issue":"21","key":"883_CR4","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1073\/pnas.0702975104","volume":"104","author":"JB Oliveira","year":"2007","unstructured":"Oliveira JB, Bidere N, Niemela JE, Zheng L, Sakai K, Nix CP, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 2007;104(21):8953\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"883_CR5","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","volume":"117","author":"M Takagi","year":"2011","unstructured":"Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 2011;117(10):2887\u201390.","journal-title":"Blood"},{"issue":"6","key":"883_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3(6):459\u201365.","journal-title":"Nat Rev Cancer"},{"key":"883_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","volume":"152","author":"ML Loh","year":"2011","unstructured":"Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011;152:677\u201387.","journal-title":"Br J Haematol"},{"key":"883_CR8","unstructured":"NOPHO-DBH AML (2012) Protocol: research study for treatment of children and adolescents with acute myeloid leukaemia 0-18 years. EudraCT Number 2012-002934-35 http:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=nopho+dbh+aml."},{"issue":"18","key":"883_CR9","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","volume":"125","author":"KR Calvo","year":"2015","unstructured":"Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, et al. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015;125(18):2753\u20138.","journal-title":"Blood"},{"issue":"10","key":"883_CR10","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","volume":"117","author":"JE Niemela","year":"2011","unstructured":"Niemela JE, Lu L, Fleisher TA, Davis J, Caminha L, Natter M, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 2011;117(10):2883\u20136.","journal-title":"Blood"},{"issue":"8","key":"883_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/DAD.0000000000001332","volume":"41","author":"TA Tran","year":"2019","unstructured":"Tran TA, Grow W, Chang CC. Superficial and deep cutaneous involvement by RAS-associated autoimmunne leukoproliferative disease (RALD cutis): a histologic mimicker of histiocytoid sweet syndrome. Am J Dermatopathol. 2019;41(8):606\u201310.","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"883_CR12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2014-01-548958","volume":"123","author":"N Lanzarotti","year":"2014","unstructured":"Lanzarotti N, Bruneau J, Trinquand A, Stolzenberg MC, Neven B, Fregeac J, et al. RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia. Blood. 2014;123(12):1960\u20133.","journal-title":"Blood"},{"key":"883_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10875-015-0163-3","volume":"35","author":"M Shiota","year":"2015","unstructured":"Shiota M, Yang X, Kubokawa M, Morishima T, Tanaka K, Mikami M, et al. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases. J Clin Immunol. 2015;35:454\u20138.","journal-title":"J Clin Immunol"},{"issue":"3","key":"883_CR14","doi-asserted-by":"publisher","first-page":"e20152891","DOI":"10.1542\/peds.2015-2891","volume":"137","author":"H Moritake","year":"2016","unstructured":"Moritake H, Takagi M, Kinoshita M, Ohara O, Yamamoto S, Moriguchi S, et al. Autoimmunity including intestinal Beh\u00e7et disease bearing the mutation in lymphocytes: a case report. Pediatrics. 2016;137(3):e20152891.","journal-title":"Pediatrics."},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2018.06.008","volume":"11","author":"K Kubara","year":"2018","unstructured":"Kubara K, Yamazaki K, Ishihara Y, Naturo T, Lin HT, Nishimura K, et al. Status of KRAS in iPSCs impacts upon self-renewal and differentiation propensity. Stem Cell Reports. 2018;11:1\u201315.","journal-title":"Stem Cell Reports"},{"key":"883_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clim.2016.12.006","volume":"175","author":"RJ Ragotte","year":"2017","unstructured":"Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, Del Bel KL, Tarailo-Graovac M, van Karnebeek C, et al. The importance of considering monogenic causes of autoimmunity: a somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus. Clin Immunol. 2017;175:143\u20136.","journal-title":"Clin Immunol"},{"key":"883_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.12986","volume":"189","author":"S Levy-Mendelovich","year":"2017","unstructured":"Levy-Mendelovich S, Lev A, Rechavi E, Barel O, Golan H, Bielorai B, et al. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing. Clin Exp Immunol. 2017;189:310\u20137.","journal-title":"Clin Exp Immunol"},{"key":"883_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPH.0000000000001276","volume":"40","author":"H Toyoda","year":"2018","unstructured":"Toyoda H, Deguchi T, Iwamoto S, Kihira K, Hori H, Komada Y, et al. Weekly rituximab followed by monthly rituximab treatment for autoimmune disease associated with RAS-associated autoimmune leukoproliferative disease. J Pediatr Hematol Oncol. 2018;40:516\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"883_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/ced.13668","volume":"43","author":"A Giacaman","year":"2018","unstructured":"Giacaman A, Bauz\u00e1 Alonso A, Salinas Sanz JA, Dapena Diaz JL, Ramos Asensio R, Ferr\u00e9s Ramis L, et al. Cutaneous involvement in an 8-year-old boy with Ras-associated autoimmune leucoproliferative disorder (RALD). Clin Exp Dermatol. 2018;43:913\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"883_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-019-0346-1","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, et al. RAS-associated autoimmune leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatr Rheumatol. 2019;17:55.","journal-title":"Pediatr Rheumatol"},{"key":"883_CR21","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1182\/blood.V128.22.4268.4268","volume":"128","author":"V Anastas","year":"2016","unstructured":"Anastas V, Wang W, Price S, Zhao Z, Koneti Rao V, Calvo KR. Indolent phenotype of RAS-associated autoimmune leukoproliferative disorder (RALD) is characterized by single somatic mutations in RAS genes with absence of cooperating mutations. (abstract). Blood. 2016;128:4268.","journal-title":"Blood"},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang D, Tarlinton DM, Kay TW, K\u00f6ntgen R, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999;286:1735\u20138.","journal-title":"Science"},{"key":"883_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479\u201389.","journal-title":"Cell"},{"key":"883_CR24","first-page":"50","volume":"287","author":"S Meynier","year":"2019","unstructured":"Meynier S, Rieux-Laucat F. FAS and RAS related apoptosis defects: from autoimmunity to leukemia Immunol. Rev. 2019;287:50\u201361.","journal-title":"Rev."},{"issue":"2","key":"883_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semarthrit.2013.04.009","volume":"43","author":"B Bader-Meunier","year":"2013","unstructured":"Bader-Meunier B, Cav\u00e9 H, Jeremiah N, Magerus A, Lanzarotti N, Rieux-Laucat F, et al. Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013;43(2):217\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"883_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, David Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"883_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ajmg.a.35290","volume":"158A","author":"CR Quaio","year":"2012","unstructured":"Quaio CR, Carvalho JF, da Silva CA, Buena C, Brasil AS, Pereira AC, et al. Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies. Am J Med Genet A. 2012;158A(5):1077\u201382.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"883_CR28","first-page":"3534","volume":"89","author":"CM Niemeyer","year":"1997","unstructured":"Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997;89(10):3534\u201343.","journal-title":"Blood."},{"issue":"12","key":"883_CR29","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1182\/blood-2006-09-046649","volume":"109","author":"K Matsuda","year":"2007","unstructured":"Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood. 2007;109(12):5477\u201380.","journal-title":"Blood"},{"key":"883_CR30","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"883_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.leukres.2008.08.022","volume":"33","author":"RJ Chan","year":"2009","unstructured":"Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res. 2009;33:355\u201362.","journal-title":"Leuk Res"},{"issue":"2","key":"883_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3324\/haematol.2009.016865","volume":"95","author":"AC de Vries","year":"2010","unstructured":"de Vries AC, Zwaan CM, van den Heuvel-Eibrink MM. Molecular basis of juvenile myelomonocytic leukemia. Haematologica. 2010;95(2):179\u201382.","journal-title":"Haematologica."},{"key":"883_CR33","unstructured":"Meynier S. Apoptosis defects discriminate the Ras-associated lymphoproliferative disease (RALD) and juvenile myelomonocytic leukaemia (JMML) conditions [abstract]. Focused meeting of the European Society for Immunodefiencies 2019."},{"key":"883_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.c.30300","volume":"157","author":"CP Kratz","year":"2011","unstructured":"Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet. 2011;157:83\u20139.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"883_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","volume":"99","author":"CM Niemeyer","year":"2014","unstructured":"Niemeyer CM. RAS diseases in children. Haematologica. 2014;99:1653\u201362.","journal-title":"Haematologica"},{"key":"883_CR36","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/leu.2013.82","volume":"27","author":"M Takagi","year":"2013","unstructured":"Takagi M, Piao J, Lin L, Kawaguchi H, Imai C, Ogawa A, et al. Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML. Leukemia. 2013;27:1926\u20138.","journal-title":"Leukemia."},{"key":"883_CR37","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","volume":"131","author":"N Murakami","year":"2018","unstructured":"Murakami N, Okuno Y, Yoshida K, Shiraishi Y, Nagae G, Suzuki K, et al. Integrated molecular profiling of juvenile myelomonocytic leukemia. Blood. 2018;131:1576\u201386.","journal-title":"Blood"},{"issue":"3","key":"883_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1182\/blood-2014-09-601690","volume":"125","author":"E Stieglitz","year":"2015","unstructured":"Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, et al. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2015;125(3):516\u201324.","journal-title":"Blood."},{"issue":"1","key":"883_CR39","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-017-02178-9","volume":"8","author":"E Stieglitz","year":"2017","unstructured":"Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun. 2017;8(1):2127.","journal-title":"Nat Commun"},{"issue":"11","key":"883_CR40","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/ng.3420","volume":"47","author":"A Caye","year":"2015","unstructured":"Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015;47(11):1334\u201340.","journal-title":"Nat Genet"},{"issue":"8","key":"883_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ng.2698","volume":"45","author":"H Sakaguchi","year":"2013","unstructured":"Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi TM, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45(8):937\u201341.","journal-title":"Nat Genet"},{"issue":"9","key":"883_CR42","doi-asserted-by":"publisher","first-page":"e26496","DOI":"10.1002\/pbc.26496","volume":"64","author":"T Osumi","year":"2017","unstructured":"Osumi T, Kato M, Ouchi-Uchiyama M, Tomizawa D, Kataoka K, Fuhii Y, et al. Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS. Pediatr Blood Cancer. 2017;64(9):e26496.","journal-title":"Pediatr Blood Cancer"},{"key":"883_CR43","doi-asserted-by":"crossref","unstructured":"Meynier S, Rieux-Laucat F. After 95 years, it\u2019s time to eRASe JMML. Blood Rev. 2020;43:100652.","DOI":"10.1016\/j.blre.2020.100652"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00883-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:07:52Z","timestamp":1659042472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00883-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,4]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Written informed consent was obtained from the patient\u2019s parents in accordance with the 1975 Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Hospitals Leuven (S58466).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}]}}